Skip to main content
OpenTrials
Completed

NCT Number: NCT03112252

App Based Study on the Symptoms of Patients With Allergic Rhinitis in the Pollen Season

App-based study of allergy patients under medication in the pollen season to determine the effect of allergic rhinitis on the quality of life.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Institute of Medical Statistics, Informatics and Epidemiology

Cologne, North Rhine-Westphalia, 50931, Germany

About this study

The project aims to determine the effects of rhinitis on everyday life and thereby identify the affected pathways, irrespective of age, gender or gender socioeconomic status to lead a healthy and active life.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patients with allergic rhinitis

Exclusion criteria

none

Treatment and study plan

no specifications. Depending on the patients

Other

patients with allergic rhinitis

Primary outcomes

  1. allergic symptoms of patients

    Time frame: one month

    allergic symptoms of patients during the pollen season

Sponsors and collaborators

Lead sponsor

University Hospital of Cologne

Other

Registry information

Official study title

App-basierte Patientenbefragung Von Allergiepatienten Unter Medikation in Der Pollenflug-Saison Zur Bestimmung Der Auswirkung Einer Allergischen Rhinitis Auf Die Lebensqualität

Important dates

Study start
2017
Primary completion
2017
Study completion
2017
First posted
Apr 13, 2017
Registry last updated
Oct 25, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.